Keto isn’t dying. It’s splitting into two camps: doctors who praise its fast results and doctors who worry about what happens after year two.
Quick Take
- A 2026 medical statement says keto and low-carb diets can help appetite control, triglycerides, and diabetes drug use.
- Cardiologists still warn keto raises bad cholesterol and lacks long-term heart-safety proof.
- Sports nutrition experts find keto offers no real edge for athletic performance.
- A widely criticized 2025 keto study claiming no artery plaque risk got retracted in 2026.
The Diet That Refuses To Disappear
Mark’s Daily Apple published a piece in September 2026 titled “Is Keto Dead?” The answer, according to the outlet, is no. Keto still works for people who use it with a clear goal, not as a permanent identity. That framing matters because keto has survived a decade of hype cycles, backlash, and rebranding without ever fully leaving the conversation.
The National Lipid Association backed that up with a formal scientific statement in August 2026. It found low-carb and ketogenic diets may help control appetite, lower triglycerides, and cut medication use in people with type 2 diabetes. That is not a full endorsement. It is a narrow, evidence-based nod for specific health goals, not a blanket claim that keto beats every other diet.
What The Latest Research Actually Shows
Newer reviews echo that split. One 2026 review found ketogenic diets produced larger, more consistent gains in weight, blood sugar, and cholesterol markers compared to milder low-carb plans. But researchers also flagged limits, including who should avoid keto entirely. People with pancreatitis, advanced liver or kidney disease, or certain cholesterol disorders face real risks on the diet. Keto is not one-size-fits-all, and doctors increasingly say so out loud.
Plant-based versions of keto and low-carb eating showed similar benefits in another 2026 study, cutting weight, LDL cholesterol, and blood sugar markers by meaningful amounts. Long-term sustainability data stayed thin across the board. That gap, short bursts of strong results paired with weak multi-year evidence, keeps showing up every time researchers dig into keto’s track record.
The Heart Health Warning That Will Not Go Away
Harvard Health has been blunt about the tradeoff. Its review of a 2024 cardiology study said keto does not meet standards for a healthy diet and may not be safe for people with existing heart disease. The concern centers on saturated fat intake driving up low-density lipoprotein (LDL) cholesterol, the kind tied to clogged arteries over time.
A 2026 cardiovascular nutrition review found keto diets beat Mediterranean-style eating on short-term weight and triglyceride numbers. But keto lost ground on LDL and total cholesterol. That tradeoff is the core tension driving the entire “is keto dead” debate. Short-term wins do not automatically add up to long-term safety, and researchers keep saying so.
Who Should Consider It, And Who Should Not
Athletes hoping keto boosts performance may want to temper expectations. The International Society of Sports Nutrition reviewed the evidence and concluded ketogenic diets push the body into nutritional ketosis but do not clearly improve exercise results for healthy, active adults. That finding undercuts one of keto’s biggest selling points among gym-goers and weekend warriors chasing an edge.
Credibility took another hit in May 2026 when a widely cited 2025 paper claiming keto does not promote artery plaque buildup was retracted after major criticism of its methods. Retractions do not erase keto’s real benefits for some people. They do remind readers to separate solid clinical statements from viral claims that skip peer review entirely.
The Verdict: Selective, Not Dead
Keto is not dead. It is graduating from a one-size-fits-all fad into a targeted tool doctors use for specific patients with specific goals, mainly weight loss and blood sugar control. For people with heart disease risk or certain metabolic conditions, the evidence still says proceed with real caution and a doctor’s guidance, not blind enthusiasm.
Sources:
marksdailyapple.com, lipid.org, pubmed.ncbi.nlm.nih.gov, bda.uk.com, health.harvard.edu, tandfonline.com
